![Xin He](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xin He
Director/Miembro de la Junta en BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION .
Perfil
Xin He is the founder of RHEI Pharmaceuticals, Inc. He is currently serving as the Director at Elpiscience Biopharma Ltd.
Additionally, he holds the position of Independent Non-Executive Director at Biosino Bio-Technology & Science, Inc. since 2024.
Dr. He is also a Non-Executive Director at Elpiscience Biopharmaceuticals, Inc. since 2019.
He obtained a doctorate degree from Yale University and a graduate degree from Princeton University.
Cargos activos de Xin He
Empresas | Cargo | Inicio |
---|---|---|
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Director/Miembro de la Junta | 28/06/2024 |
Elpiscience Biopharma Ltd.
![]() Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | - |
Elpiscience Biopharmaceuticals, Inc.
![]() Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | 28/12/2019 |
Antiguos cargos conocidos de Xin He.
Empresas | Cargo | Fin |
---|---|---|
RHEI Pharmaceuticals, Inc.
![]() RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Director Ejecutivo | - |
Formación de Xin He.
Yale University | Doctorate Degree |
Princeton University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Health Technology |
Empresas privadas | 3 |
---|---|
RHEI Pharmaceuticals, Inc.
![]() RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
Elpiscience Biopharma Ltd.
![]() Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
Elpiscience Biopharmaceuticals, Inc.
![]() Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Xin He